Park, Hye Yun
Lee, Suh-Young
Kang, Danbee
Cho, Juhee
Lee, Hyun
Lim, Seong Yong
Yoon, Ho Il
Ra, Seung Won
Kim, Ki Uk
Oh, Yeon-Mok
Sin, Don D.
Lee, Sang-Do
Park, Yong Bum
Funding for this research was provided by:
the Korean Health 21 R&D Project, Ministry of Health and Welfare
Samsung Medical Center Foundation for Medical Research
Article History
Received: 6 December 2017
Accepted: 11 February 2018
First Online: 2 March 2018
Ethics approval and consent to participate
: The study protocol was approved by the Institutional Review Board of Asan Medical Center (no. 2005–0010). Written informed consent was obtained from all participants.
: The authors give our consent for publication.
: H.Y.P. has received lecture fees from AstraZeneca, Novartis and Boehringer-Ingelheim.D.D.S. is funded by the Canada Research Chair Program and has received honoraria for speaking engagements from Boehringer Ingelheim, AstraZenca, Regeneron and Sanofi Aventis over the past 18 months. He has also received research funding from BI, AZ and Merck during this time.None declared (S-Y.L., D.K., J.C., H.L., S.Y.L., H.I.Y., S.W.R., K.U.K., Y-M.O., S-D.L., Y.B.P.).
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.